Navigation Links
Pharmaceutical Manufacturing in China Industry Research Report – Now Available from IBISWorld
Date:2/2/2013

San Francisco, CA (PRWEB) February 02, 2013

Revenue for the Pharmaceutical Manufacturing industry in China is expected to increase at an annualized rate of 22.1% in the five years to 2012 to reach $78.8 billion, says IBISWorld. Growth has been largely driven by rising market demand and the rising income levels of consumers. In addition, over the past five years the government amended the rebate practices of hospitals for pharmaceutical and medicine products to limit overcharging and price gouging of consumers. In the past, many consumers could not afford to purchase medicine or see a doctor.

In recent years, concentration levels in the global pharmaceutical industry have increased as major players merged to minimize rising R&D costs, reduce development times and increase global marketing power. Within the Pharmaceutical Manufacturing industry in China, concentration is low, with the top four players accounting for 15.0% of total industry revenue in 2012. The industry's concentration level is expected to increase as small and inefficient players leave the industry and large players become more competitive, says IBISWorld.

The government will continue to implement policies to restrict and decrease medicine prices, allowing more consumers to purchase medicine when required. This will increase demand for the Pharmaceutical Manufacturing industry in China. Furthermore, future healthcare reforms will allow drugstores to surpass hospitals as the major distribution channel for pharmaceuticals, says IBISWorld.

For more information, visit IBISWorld’s Pharmaceutical Manufacturing in China industry report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld Industry Report Key Topics

The Pharmaceutical Manufacturing industry in China is primarily engaged in the manufacture of chemical medicinal and pharmaceutical products in various formats, including ampoules, tablets, capsules, vials, ointments, powders, solutions, suspensions and radioactive medicine. These products are then sold via pharmacies or distributed via hospitals. Biological and veterinary medicine products are not included in this industry.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.

Read the full story at http://www.prweb.com/releases/china/pharmaceutical-mfg/prweb10381949.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bactolac Pharmaceutical Weighs In With New Year’s Resolution Support with Full-Service Weight Control Products Process
2. Blue Door Pharma and Global Energy Markets Strike Global Export Agreement for Meningitis Vaccine and Pharmaceuticals
3. Devalued and distrusted: Can the pharmaceutical industry restore its broken image?
4. UBC professor wins Canadas top pharmaceutical research award
5. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
6. Environmentally friendly chemistry important for manufacturing pharmaceuticals
7. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
8. Medical care presents update on pharmaceutical health services research
9. Scientists use sound waves to levitate liquids, improve pharmaceuticals
10. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
11. Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... The Executives, Staff & Clients of MGE: Management Experts ... for Tots Literacy Campaign at their Semi-Annual Graduation and Fundraiser Event at MGE’s St. ... ranks at number 14 internationally in literacy. Statistically, a direct relation can be a ...
(Date:3/28/2017)... ... 2017 , ... Public relations pros work hard to earn placements and ... While many results are clear, much of PR is hard to quantify. Goal-setting and ... to measurement, firms should always take an all-inclusive approach that takes both traditional and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Thank you to all who ... 8-10. , This event was exclusive to providers and offered an opportunity to ... took place at the Manchester Grand Hyatt where attendees gathered for a lively discussion ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... patients for clear braces. People who want straight teeth without the extensive time ... in Clearwater, FL, without acquiring a referral. A custom-designed series of virtually ...
(Date:3/27/2017)... ... March 27, 2017 , ... This is the ... popHealth Community in 2014. It is the culmination of collaborative efforts by ... Project Group. OSEHRA Organizational Member Zato Health co-funded the ONC certification and provided ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... March 28, 2017 Elysium Health ... Cambridge academic scientists ... The Milner Therapeutics Institute today announces Elysium Health ... has committed significant investment for collaborative projects with academic researchers ... years. This is the first major research investment outside the ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
(Date:3/27/2017)... March 27, 2017 LightIntegra Technology Inc. today ... "Bill" Dubiel as President and Chief Executive Officer effective ... the Board of Directors of LightIntegra. Paul Geyer ... of LightIntegra. "This is the perfect ... Chief Executive Officer. We,ve selected a very strong leader ...
Breaking Medicine Technology: